11/06/2013
Federal Register Notice: FDA is making available a draft guidance for industry entitled Bioequivalence Recommendations for Iron Su...11/06/2013
Federal Register Notice: FDA will hold a public meeting 2/7/14 on patient-focused drug development for sickle cell disease. The me...11/06/2013
Federal Register Notice: FDA is making available a draft guidance for industry entitled Pulmonary Tuberculosis: Developing Drugs f...10/30/2013
Federal Register Notice: FDA’s Endocrinologic and Metabolic Drugs Advisory Committee will meet 12/11 from 8 a.m. to 5 p.m. a...10/30/2013
Federal Register Notice: FDA’s Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Co...